Surgery for local and locally advanced non-small cell lung cancer

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 4, 2005, Pages

  Manser, Renée ^a   Wright, Gavin ^a   Hart, David ^a   Byrnes, Graham ^b   Campbell, Don ^c   Wainer, Zoe ^a   Tort, Sera ^d  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29944447580     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004699.pub2     Document Type: Review

References (76)

1. Albain KS, Scott CB, Rusch VR, Turrisi AT, Shepherd FA, Smith C, et al. SWOG, NCIC, ECOG, CALGB, NCCTG. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Initital results from intergroup trial 0139 (RTOG 93-09). Proceedings of American Society of Clinical Oncology 2003;22:621 (abstract no 2497).
2. Albain KS, Scott CB, Rusch VR, Turrisi AT, Shepherd SA, Smith C, et al. Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09). Lung Cancer 2003;41(Suppl 2):4.
3. Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Che Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green M, Miller RC, Ley J, Sause WT, Cox JD. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small cell lung cancer: a phase III randomised controlled trial. Lancet 2009;374:379-86.
4. Ginsberg RJ, Rubinstein LV for the Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Annals of Thoracic Surgery 1995;60:615-23.
5. Rubinstein LV, Ginsberg RJ. Lobectomy versus limited resection in T1 N0 lung cancer. Annals of Thoracic Surgery 1996;62:1249-50.
6. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: Results of a prospective randomized controlled trial. Annals of Surgery 1998;227(1):138-44.
7. Izbicki JR, Thetter O, Habekost M, Karg O, Passlick B, Kubuschok B, et al. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. British Journal of Surgery 1994;81(2):229-35.
8. Johnstone DW, Byhardt RW, Ettinger D, Scott CB. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. International Journal of Radiation Oncology, Biology, Physics 2002;54(2):365-9.
9. Morrison R, Deeley TJ, Cleland WP. The treatment of carcinoma of the bronchus: A clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1963;1:683-4.
10. Warram J, on behalf of collaborating investigators. Preoperative irradiation of cancer of the lung: Preliminary report of a therapeutic trial (a collaborative study). Cancer 1969;23:419-29.
11. Warram J, on behalf of collaborating investigators. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial (a collaborative study). Cancer 1975;36(3):914-25.
12. Shepherd FA, Johnston MR, Payne D, Burkes R, Deslauriers J, Cormier Y, et al. Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study. British Journal of Cancer 1998;78(5):683-5.
13. Stathopoulos GP, Papakostas P, Malamos NA, Samelis GF, Moschopoulos N. Chemo-radiotherapy versus chemo-surgery in stage IIIA non-small cell lung cancer. Oncology Reports 1996;3:673-6.
14. Stephens RJ, Girling DJ, Hopwood P, Thatcher N on behalf of the Medical Research Council Lung Cancer Working Party. A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer. Lung Cancer 2005;49:395-400.
15. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World Journal of Surgery 1998;22:290-5.
16. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World Journal of Surgery 2000;24:27-31.
17. Splinter TAW, Kirkpatrick A, van Meerbeeck J, Vanteenkiste J, Postmus P, Giaccone G on behalf of the EORTC Lung Cancer Cooperative group and VKSL. Randomised trial of surgery versus radiotherapy in patients with stage IIIA non-small cell lung cancer after response to induction chemotherapy, intergroup study 08941 (abstract). Proceedings of American Society of Clinical Oncology 1998;17:453a.
18. Splinter TAW, van Schil PE, Kramer GWPM, van Meerbeeck J, Gregor A, Rocmans P, et al. Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non-small cell lung cancer after response to induction chemotherapy (EORTC 08941). Clinical Lung Cancer 2000;2(1):69-72.
19. Van Meerbeeck JP, Vansteenkiste JF, Van Schil PEY, Weynants P, Scagliotti G, Darwish S, et al. Neoadjuvant chemotherapy (CT) followed by surgical resection (SR) or thoracic radiotherapy (TRT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): A multicentric randomised European experience. European Respiratory Journal 1997;10(Supplement 25):153 (abstract).
20. van Meerbeeck, JP, Kramer GWPM, Van Schil PEY, Legrand C, Smit EF, Schramel F, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 Non-small cell lung cancer. J Natl Cancer Inst 2007;99:442-50.
21. Wu YL, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
22. Wu YL, Wang S, Huang Z, et al. Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomised clinical trial. Zhonghua Zhong Liu Za Zhi 2001;23(1):43-5.
23. Bretel JJ, Arrigada R, Le Chevalier T, Baldeyrou P, Grunenwald D, Le Pechoux C, et al. Optimisation of combination radiotherapy and chemotherapy in non-small cell lung cancer [Optimisation de l'association radiotherapie et chimiotherapie dans les carcinomes bronchiques non a petites cellules]. Cancer Radiotherapie 1997;1:148-53.
24. Cox JD, Azarnia N, Byhardt RW, Shin KH, Emami B, Perez CA. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the Radiation Therapy Oncology Group. Int J Radiation Oncology Biol. Phys. 1991;20(1):7-12.
25. Durci ML, Komaki R, Oswald MJ, Mountain CF. Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis. International Journal of Radiation Oncology, Biology, Physics 1991;21(3):629-36.
26. Ferguson MK, Karrison T. Does pneumonectomy for lung cancer adversely influence long-term survival?. The Journal of Thoracic and Cardiovascular Surgery 2000;119(3):440-8.
27. Harpole DH, Herndon JE, Young WG, Wolfe WG, Sabiston DC. Stage I Nonsmall cell lung cancer: A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76(5):788-96.
28. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Annals of Thoracic Surgery 2000;70(2):358-65.
29. Kirby TJ, Mack MJ, Landreneau RJ, Rice TW. Lobectomy- video-assisted thoracic surgery versus muscle sparing thoracotomy: A randomized trial. Journal of Thoracic and Cardiovascular Surgery 1995;109(5):997-1002.
30. Anonymous. Comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. First report to the Medical Research Council by the working-party on the evaluation of different methods of therapy in carcinoma of the bronchus. Lancet 1966;2(7471):979-86.
31. Fox W, Scalding JG. Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. Lancet 1973;2(7820):63-5.
32. Miller AB, Fox W, Tall R. Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small-celled or oat-celled carcinoma of the bronchus. Lancet 1969;2(7619):501-5.
33. Pitz CCM, Maas KW, Van Swieten HA, de la Riviere AB, Hofman P, Schramel FMNH. Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer. Annals of Thoracic Surgery 2002;74(1):164-9.
34. Sugiura H, Morikawa T, Kaji M, Sasamura Y, Kondo S, Katoh H. Long-term benefits for the quality of life after video-assisted thoracoscopic lobectomy in patients with lung cancer. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 1999;9(6):403-8.
35. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, et al. Equivalent outcome of patients with clinical stage IIIA non-small cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. International Journal of Radiation Oncology, Biology, Physics 2004;58(1):204-12.
36. Van Kooten M, Rosenberg M, Orlando M, Morero J, Vilanova M, Rojas O, et al. Neoadjuvant chemotherapy with gemcitabine and cisplatin in stage IIIA/B non-small cell lung cancer. Investigational New Drugs 2002;20:439-46.
37. Yano T, Yokoyama H, Yoshino I, Tayama K, Asoh H, Hata K, Ichinose Y. Results of a limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung. Journal of the American College of Surgeons 1995;181:33-7.
38. Yim APC, Wan S, Lee PW, Arifi AA. VATS lobectomy reduces cytokine responses compared with conventional surgery. Annals of Thoracic Surgery 2000;70:243-7.
39. Allen M (study chair) for the American College of Surgeons Oncology Group (Thoracic Organ Site Committee). Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in patients with N0 or N1 (less than hilar) non-small cell lung cancer. http://www.acosog.org/studies/synopses/Z0030_Synopsis.pdf accessed 12th July 2004.
40. Detterbeck FC, Egan TM. Surgery for stage II non-small cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG editor(s). Diagnosis and treatment of lung cancer - an evidence based guide. Philadelphia: W.B. Saunders Company, 2001:191-7.
41. Farray D, Mirkovic N, Albain KS. Multimodality Therapy for Stage III Non-Small-Cell Lung Cancer. Journal of Clinical Oncology 2005;23(14):3257-69.
42. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New England Journal of Medicine 1985;312(25):1604-08.
43. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4.
44. Flehinger BJ, Kimmel M, Melamed MR. The effect of surgical treatment on survival from early lung cancer: Implications for screening. Chest 1992;101:1013-18.
45. Gloeckler Ries LA, Reichman ME, Reidel Lewis D, Hankey BJ, Edwards BK. Cancer survival and incidence from the Surveillence Epidemiology, and End Results (SEER) Program. The Oncologist 2003;8(6):541-52.
46. Hensing, TA, Halle JS, Socinski MA. Chemotherapy for stage IIIA, B Non-small cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG editor(s). Diagnosis and treatment of lung cancer - an evidence based guide. Philadelphia: W.B. Saunders Company, 2001:291-303.
47. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008.
48. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41(3):245-58.
49. Jones DR, Detterbeck FC. Surgery for stage I non-small cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG editor(s). Diagnosis and treatment of lung cancer- an evidence based guide. Philadelphia: W.B. Saunders Company, 2001:177-90.
50. Keller SM. Complete mediastinal lymph node dissection - does it make a difference?. Lung Cancer 2002;36:7-8.
51. Kiser AC, Detterbeck FC. Chapter 8: General aspects of surgical treatment. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG editor(s). Diagnosis and treatment of lung cancer - an evidence based guide. Philadelphia: W.B. Saunders Company, 2001:133-47.
52. Lerdele FA, Niewoehner DE. Lung cancer surgery: a critical review of the evidence. Archives of Internal Medicine 1994;154(21):2397-401.
53. Martini N, Flehinger BJ, Zaman MB, Beattie EJ. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Annals of Surgery 1983;198:386-97.
54. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surgical Clinics of North America 1987;67:1037.
55. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Annals of Thoracic Surgery 1992;54:460-6.
56. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Supplement 4):225-33.
57. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111(6):1710-17.
58. Naruke T, Suemasu K, Ishikawa S. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. The Journal of Thoracic and Cardiovascular Surgery. 1976;71(2):279-85.
59. Nesbitt JC, Putman JB, Walsh GL, Roth JA, Mountain CF. Survival in early stage non-small cell lung cancer. Annals of Thoracic Surgery 1995;60:466-72.
60. Ost D, Goldberg J, Rolnitzky L, Rom WN. Survival after Surgery in Stage IA and IB Non Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine 2008;177:516-23.
61. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
62. Qureshi AI, Hutson AD, Harbaugh RE, Stieg PE, Hopkins LN. Methods and design considerations for randomised clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases. Neurosurgery 2004;54:248-67.
63. Reif MS, Socinski MA, Rivera MP. Evidence-based medicine in the treatment of non-small cell lung cancer. Clinics in Chest Medicine 2000;21(1):107-20.
64. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;123(3 Suppl):243S-265S.
65. Rowell NP, Williams C. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database of Systematic Reviews 2001, Issue 1. [Art. No.: CD002935. DOI: 10.1002/14651858.CD002935]
66. Rowell NP, O'Rourke N. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database of Systematic Reviews 2004, Issue 4. [Art. No.: CD002140. DOI: 10.1002/14651858.CD002140.pub2]
67. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408-12.
68. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence Based Clinical Practice Guidelines (2nd Edition). Chest 2007;132:234S-242S.
69. Smythe WR. Treatment of stage I non-small cell lung carcinoma. Chest 2003;123(Supplement 1):181-7.
70. Sobin LH, Wittekind CH. UICC TNM classification of malignant tumours. 5th Edition. New York: Wiley-Liss, 1997:12-3.
71. Sobue T, Suzuki T, Matsuda M, Kuroishi T, Ikeda S, Naruke T, et al. Survival for clinical stage I lung cancer not surgically treated: Comparison between screen-detected and symptom-detected cases. Cancer 1992;69:685-92.
72. Department of Health Standing Medical Advisory Committee. The management of lung cancer: current clinical practices; report of a working group to the Standing Medical Advisory Committee. Department of Health, 1994.
73. Thomas P, Doddoli C, Thirion X, Ghez O, Payan-Defais MJ, Giudicelli R, et al. Stage I Non-Small Cell Lung Cancer: A Pragmatic Approach to Prognosis After Complete Resection. Annals of Thoracic Surgery 2002;73:1065-70.
74. Tierney, JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
75. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Statistics in Medicine 1991;10:1665-77.
76. Manser R, Wright G, Hart D, Byrnes G, Campbell D. Surgery for early stage non-small cell lung cancer. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD004699.pub2]